Header Logo

Connection

Naoko Takebe to Tissue Distribution

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Tissue Distribution.
Naoko Takebe
Connection Strength
0.045
Tissue Distribution
  1. Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903). Clin Cancer Res. 2021 03 15; 27(6):1604-1611.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.